178 related articles for article (PubMed ID: 20679491)
1. Interferon consensus sequence binding protein (ICSBP) decreases beta-catenin activity in myeloid cells by repressing GAS2 transcription.
Huang W; Zhou W; Saberwal G; Konieczna I; Horvath E; Katsoulidis E; Platanias LC; Eklund EA
Mol Cell Biol; 2010 Oct; 30(19):4575-94. PubMed ID: 20679491
[TBL] [Abstract][Full Text] [Related]
2. Bcr-abl regulates Stat5 through Shp2, the interferon consensus sequence binding protein (Icsbp/Irf8), growth arrest specific 2 (Gas2) and calpain.
Hjort EE; Huang W; Hu L; Eklund EA
Oncotarget; 2016 Nov; 7(47):77635-77650. PubMed ID: 27769062
[TBL] [Abstract][Full Text] [Related]
3. The leukemia-associated fusion protein Tel-platelet-derived growth factor receptor β (Tel-PdgfRβ) inhibits transcriptional repression of PTPN13 gene by interferon consensus sequence binding protein (Icsbp).
Huang W; Hu L; Bei L; Hjort E; Eklund EA
J Biol Chem; 2012 Mar; 287(11):8110-25. PubMed ID: 22262849
[TBL] [Abstract][Full Text] [Related]
4. The Interferon Consensus Sequence Binding Protein (Icsbp/Irf8) Is Required for Termination of Emergency Granulopoiesis.
Hu L; Huang W; Hjort EE; Bei L; Platanias LC; Eklund EA
J Biol Chem; 2016 Feb; 291(8):4107-20. PubMed ID: 26683374
[TBL] [Abstract][Full Text] [Related]
5. The interferon consensus sequence binding protein (ICSBP/IRF8) activates transcription of the FANCF gene during myeloid differentiation.
Saberwal G; Horvath E; Hu L; Zhu C; Hjort E; Eklund EA
J Biol Chem; 2009 Nov; 284(48):33242-54. PubMed ID: 19801548
[TBL] [Abstract][Full Text] [Related]
6. Fas-associated phosphatase 1 mediates Fas resistance in myeloid progenitor cells expressing the Bcr-abl oncogene.
Huang W; Bei L; Eklund EA
Leuk Lymphoma; 2013 Mar; 54(3):619-30. PubMed ID: 22891763
[TBL] [Abstract][Full Text] [Related]
7. The interferon consensus sequence-binding protein (ICSBP/IRF8) represses PTPN13 gene transcription in differentiating myeloid cells.
Huang W; Zhu C; Wang H; Horvath E; Eklund EA
J Biol Chem; 2008 Mar; 283(12):7921-35. PubMed ID: 18195016
[TBL] [Abstract][Full Text] [Related]
8. ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells.
Tamura T; Kong HJ; Tunyaplin C; Tsujimura H; Calame K; Ozato K
Blood; 2003 Dec; 102(13):4547-54. PubMed ID: 12933588
[TBL] [Abstract][Full Text] [Related]
9. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias.
Schmidt M; Nagel S; Proba J; Thiede C; Ritter M; Waring JF; Rosenbauer F; Huhn D; Wittig B; Horak I; Neubauer A
Blood; 1998 Jan; 91(1):22-9. PubMed ID: 9414265
[TBL] [Abstract][Full Text] [Related]
10. Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder.
Hao SX; Ren R
Mol Cell Biol; 2000 Feb; 20(4):1149-61. PubMed ID: 10648600
[TBL] [Abstract][Full Text] [Related]
11. The interferon consensus sequence-binding protein activates transcription of the gene encoding neurofibromin 1.
Zhu C; Saberwal G; Lu Y; Platanias LC; Eklund EA
J Biol Chem; 2004 Dec; 279(49):50874-85. PubMed ID: 15371411
[TBL] [Abstract][Full Text] [Related]
12. Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2.
Burchert A; Cai D; Hofbauer LC; Samuelsson MK; Slater EP; Duyster J; Ritter M; Hochhaus A; Müller R; Eilers M; Schmidt M; Neubauer A
Blood; 2004 May; 103(9):3480-9. PubMed ID: 14656881
[TBL] [Abstract][Full Text] [Related]
13. Expression of interferon consensus sequence binding protein induces potent immunity against BCR/ABL-induced leukemia.
Deng M; Daley GQ
Blood; 2001 Jun; 97(11):3491-7. PubMed ID: 11369642
[TBL] [Abstract][Full Text] [Related]
14. Growth arrest specific 2 is up-regulated in chronic myeloid leukemia cells and required for their growth.
Zhou H; Ge Y; Sun L; Ma W; Wu J; Zhang X; Hu X; Eaves CJ; Wu D; Zhao Y
PLoS One; 2014; 9(1):e86195. PubMed ID: 24465953
[TBL] [Abstract][Full Text] [Related]
15. Gamma interferon triggers interaction between ICSBP (IRF-8) and TEL, recruiting the histone deacetylase HDAC3 to the interferon-responsive element.
Kuwata T; Gongora C; Kanno Y; Sakaguchi K; Tamura T; Kanno T; Basrur V; Martinez R; Appella E; Golub T; Ozato K
Mol Cell Biol; 2002 Nov; 22(21):7439-48. PubMed ID: 12370291
[TBL] [Abstract][Full Text] [Related]
16. The interferon regulatory factor ICSBP/IRF-8 in combination with PU.1 up-regulates expression of tumor suppressor p15(Ink4b) in murine myeloid cells.
Schmidt M; Bies J; Tamura T; Ozato K; Wolff L
Blood; 2004 Jun; 103(11):4142-9. PubMed ID: 14976051
[TBL] [Abstract][Full Text] [Related]
17. PU.1, interferon regulatory factor (IRF) 2, and the interferon consensus sequence-binding protein (ICSBP/IRF8) cooperate to activate NF1 transcription in differentiating myeloid cells.
Huang W; Horvath E; Eklund EA
J Biol Chem; 2007 Mar; 282(9):6629-43. PubMed ID: 17200120
[TBL] [Abstract][Full Text] [Related]
18. Leukemia-associated, constitutively active mutants of SHP2 protein tyrosine phosphatase inhibit NF1 transcriptional activation by the interferon consensus sequence binding protein.
Huang W; Saberwal G; Horvath E; Zhu C; Lindsey S; Eklund EA
Mol Cell Biol; 2006 Sep; 26(17):6311-32. PubMed ID: 16914719
[TBL] [Abstract][Full Text] [Related]
19. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells.
Tamura T; Ozato K
J Interferon Cytokine Res; 2002 Jan; 22(1):145-52. PubMed ID: 11846985
[TBL] [Abstract][Full Text] [Related]
20. Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-alpha.
Schmidt M; Hochhaus A; Nitsche A; Hehlmann R; Neubauer A
Blood; 2001 Jun; 97(11):3648-50. PubMed ID: 11369663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
